Low PRKCA mRNA expression was statistically associated with a best RFS of breast cancer patients with negative estrogen receptor tumors (HR = 1.36, p = 0.027) (Fig. 7a), while RARA mRNA expression did not affect RFS probability (Fig. 7b). This evidence concerns the gene RARA and breast carcinoma.